LM-108 | m-entrepreneurship.com

Product Name :
LM-108

Search keywords :
CCR8

drugId :
null

Target Vo:
C-C chemokine receptor type 8

Target Vo Short Name :
CCR8

Moa_Name:
C-C chemokine receptor type 8 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
LaNova Medicines Ltd

Active Company_Name :
Fudan University

Active Indication_Name:
Triple Negative Breast Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
JNK2 Antibody
NLRP3 Antibody
Cathepsin K Antibody: Cathepsin K Antibody is an unconjugated, approximately 36 kDa, rabbit-derived, anti-Cathepsin K polyclonal antibody. Cathepsin K Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in rat, and predicted: human, mouse, dog, pig, cow, horse, guinea pig background without labeling.

Author: Betaine hydrochloride

Related Posts